Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus.
Opioid-associated amnestic syndrome: Description of the syndrome and validation of a proposed definition.
What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.
Toll-like Receptors and the Control of Immunity.
See All 28 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Toll-like Receptors and the Control of Immunity.
Fitzgerald KA, Kagan JC. Toll-like Receptors and the Control of Immunity. Cell. 2020 03 19; 180(6):1044-1066.
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Humans
Immunity, Innate
Inflammation
Organelles
Signal Transduction
Toll-Like Receptors
authors with profiles
Katherine A Fitzgerald PhD